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Infrapopliteal arteriesAbstract Objective: To compare the outcomes of infrapopliteal angioplasty between diabetic
patients and non-diabetic patients with critical limb ischemia.
Patients and methods: From March 2014 to December 2014, infrapopliteal angioplasty was per-
formed on 60 limbs (43 men and 17 women with mean age 70.13 years) with the CLI (Fontaine’s
grade III or IV). The number of diabetic patients was 40 (66.66%). Follow-up included clinical
examination for rest pain improvement and ischemic ulcer healing, and duplex-documented target
vessel patency or re-stenosis at discharge and at 3 months.
Results: The technical success rate was 100% in diabetic and non-diabetic groups. The ulcer heal-
ing rate was 33/37 (89.18%) in diabetic patients vs. 14/15 (93.3%) in non-diabetic patients. And the
re-stenosis and re-occlusion rates of treated vessels after 3 months were 10.0% in diabetic vs. 5.0%
in non-diabetic groups.
Conclusion: There were no significant differences between the 2 groups in the technical success rate,
but the 3 months clinical success rate and the primary patency rate were better in non-diabetic than
in diabetic patients with no significant differences.
 2016 The Egyptian Society of Radiology and Nuclear Medicine. Production and hosting by Elsevier.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-
nd/4.0/).1. Introduction
Peripheral vascular diseases (PVD) in diabetic patients consti-
tutes a major clinical problem and is associated with higher
morbidity and mortality (1). Diabetic patients are 5-fold more
likely to develop critical limb ischemia (CLI) than non-diabetic
patients (2). One serious complication of PVD is gangrene,
which accounts for up to 50% of lower limb amputations in
diabetic patients in the Western world (2).
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cal method of revascularization in treating the critical limb
ischemia (CLI) (3,4) in peripheral vascular diseases (PVD),
and replacing the surgical bypass which was considered as
a standard method due to its better anatomical and clinical
durability relative to the other revascularization methods
(5,6).
Some studies revealed that infrapopliteal revascularization
in diabetic patients with CLI reduces the rate of amputation,
these studies dealt with heterogeneous stages of ischemia such
as resting pain or tissue lesions, and furthermore, the most fre-
quently treated vessels were the distal Popliteal artery and the
Tibio-peroneal trunk (7,8).
In a later study, the successful endovascular procedure led
to a high percentage of limb salvage at long-term follow-up
in the patients with ischemic diabetic foot and isolated
below-knee lesions (9).
The aim of the works was to compare the outcomes of
infrapopliteal angioplasty between the diabetic and non-
diabetic patients with CLI.2. Patients & methods
This study was done between March 2014 and December 2014,
and 60 limbs in 60 patients with CLI (40 diabetic) and (20 non-
diabetic) had infrapopliteal arterial lesions, were treated with
balloon angioplasty. All procedures were done in Istituto DI
Cura Citta‘ DI Pavia (Italy) in the angiographic room on
GE innova 3100, USA.
2.1. Patients
2.1.1. Demographic data
 In the diabetic group 26 patients were males and 14 females,
their mean age was 71.43 ± 2.41 years and more than half
of this group had hypertension (72.5%), 47.5% were smok-
ers and 40.0% had dyslipidemia, while in the non-diabetic
group 17 were males and 3 females, 50.0% of patients
had hypertension and were smokers as well as 25.0% had
dyslipidemia.
2.1.2. Inclusion criteria
 Patients with critical limb ischemia, having a Fontaine‘s
stage III (ischemic rest pain) or Fontaine‘s stage IV
(ischemic leg or foot ulcers).
 Patients have single or multiple segments of stenosis
(>50%) or occlusions involving the infrapopliteal arteries.
 The presence of associated femoro-popliteal diseases did
not exclude the patient from the study.
2.1.3. Exclusion criteria
 Acute limb ischemia.
 Active bleeding or bleeding diathesis.
 Recent hemorrhagic stroke or any other CNS abnormality
with increased risk of hemorrhage.
 Previous implanted stent at the index site. When Acetylsalicylic acid (aspirin), Clopidogrel (Plavix)
and Heparin are contraindicated.
 Known allergy to iodinated contrast media.
 Renal disease under medical treatment (serum creatinine
>3 mg/dL).
2.1.4. Patients are classified according to Fontaine‘s clinical
classification (10) into 4 stages
Stage I: Asymptomatic, incomplete blood vessel
obstruction.
Stage II: Mild claudication pain in limb.
Stage II A: Claudication at a distance of greater than
200 m.
Stage II B: Claudication at a distance of less than 200 m.
Stage III: Rest pain, mostly in the feet.
Stage IV: Necrosis and/or gangrene of the limb.
Patients those included in this study are stages III and IV.
2.1.5. All included lower limb arteries are examined by Doppler
ultrasound before angioplasty procedures
2.2. Methods
2.2.1. Pre-procedural medications
All patients received oral antiplatelet in form of salicylic acid
(150 mg) and Plavix (75 mg) twice daily and good hydration
by normal saline for 6 h before the procedure.
2.2.2. The procedure
The procedure was done under local anesthesia 10 cc of lido-
caine 2% infiltrated around the puncture site. Femoral punc-
ture was done through either ipsi-lateral anti-grade or
contra-lateral approach of the common femoral artery.
A 5-F sheath is introduced and passed over a guide wire, to
perform a preliminary angiographic study using diluted (50%)
non-ionic contrast medium from the sidearm sheath. Once the
sheath is localized in the femoral artery, the patient is system-
ically heparinized with intra-arterial bolus of 5000 units of un-
fractionated heparin.
Selective angiography of the infrainguinal and infrapopli-
teal arteries was performed with a 5-F multipurpose diagnostic
catheter. After obtaining the pre-interventional angiography,
the lesions of the femoral and popliteal artery (if present) were
treated to establish good inflow to the calf by angioplasty.
Afterward a hydrophilic guidewire (Aqua Liner Angled
.01800  150 cm) with a steerable soft atraumatic tip was then
used to pass intraluminally in the infrapopliteal lesions, if
failed we dissect the intima by subintimal approach in an ante-
grade direction.
After crossing the lesion, dilation using Bantam PTA
catheter with a diameter of 3 mm and a length of 130 mm by
6 atmospheres for 60 s was performed with an inflator device.
Vessel recanalization was considered successful when direct
flow was obtained in the treated vessel, with no significant
residual stenosis along the whole artery.
The sheath was removed at the completion of the procedure
over the guide wire and hemostasis was achieved by manual
compression.
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All patients received 150 mg acetylsalicylate (ASA) indefinitely
on a lifetime basis plus 75 mg Plavix for 1 month.
2.3. Follow-up
Follow-up was scheduled at 1 day and 3 months post proce-
dures for the following: clinical improvement according to
Fontaine‘s classification by absent resting pain and/or progres-
sive tissue healing, and Duplex Ultrasound evaluation by ankle
peak systolic velocity. Peak systolic velocity (PSV) in the
target-vessel was determined and compared with that in the
preceding normal segment. A focal increase of at least 140%
in the PSV was considered indicative of >50% re-stenosis at
that site (11).
3. Results
* In the diabetic group 26 patients were males and 14 females,
their mean age was 71.43 ± 2.41 years and more than half
of this group had hypertension (72.5%), 47.5% were smok-
ers and 40.0% had dyslipidemia, while in the non-diabetic
group 17 were males and 3 females, 50.0% of patients
had hypertension and were smokers as well as 25.0% had
dyslipidemia.
* In the diabetic group the anterior tibial artery was the most
affected artery in 20 patients (50.0%) followed by the pos-
terior tibial artery in 8 patients (20.0%), while in non-dia-
betic patients the posterior tibial artery was the most
affected artery in 8 patients (40.0%), followed by the ante-
rior tibial and peroneal arteries in 4 patients of each artery
(20.0%).
* Out of 40 diabetic patients, 92.5% of patients had ischemic
skin ulcer and 20.0% had rest pain. Out of 20 non-diabetic
patients, 15 patients had ischemic skin ulcer (25.0%) and 9
patients had rest pain (45.0%) with significant difference
between the two groups (Table 1).Table 1 Relation between diabetic and non-diabetic patients with c
Item D.M ‘‘n= 40” %
1- Age ‘‘ys.” 71.43 ± 2.41 –
2- Sex:
 Male 26 65.0%
 Female 14 35.0%
3-Co-morbidity:
 H.T 29 72.5%
 Smoking 19 47.5%
 Dyslipidemia 16 40.0%
4- Distribution of vs.:
 Anterior tibial A. 20 50.0%
 Tibio-peroneal A. 2 5.0%
 Posterior tibial A. 8 20.0%
 Peroneal A. 7 17.5%
 Pedal A. 2 5.0%
 Plantar A. 1 2.5%
5- Symptoms:
 Rest pain. 3 7.5%
 Ischemic ulcer. 32 80.0%
 Rest pain + Ulcer 5 12.5%* 60 infrapopliteal arterial lesions were treated in 60 patients
with no major complication requiring surgical intervention
after PTA.
* Follow-up with Doppler ultrasound 1 day post procedures
‘‘Initial technical success‘‘ was achieved in 60 limbs by
(100%). Follow-up with clinical examination after
3 months ‘‘primary clinical success” revealed persistent
ischemic ulcer in 4 diabetic patients and in one non-diabetic
patient with significant difference between the two groups
(P< 0.03). Doppler ultrasound of the treated vessels after
3 months ‘‘primary patency rate” revealed high frequency
of re-stenosis and re-occlusion in diabetic patients than in
the non-diabetic patients but with no significant difference,
Table 2.
Sample of cases attached is shown in Figs. 1–4.
4. Discussion
Although bypass surgery using outflow vessels below the ankle
should be considered the standard treatment in patients with
CLI due to infrapopliteal arterial disease (12), this requires a
good vein conduit and at least one open foot artery and is
associated with considerable perioperative mortality, postoper-
ative complications, myocardial infarction, and early reopera-
tion for graft thrombosis (13).
Diabetic patients are more likely to develop CLI and its
serious complications including gangrene, and to have higher
morbidity and mortality (1,2).
Diabetes mellitus is the possible determinant factor of graft
failure in patients with CLI (14).
For these reasons, infrapopliteal angioplasty is currently
proposed as the primary treatment for CLI in diabetic patients
(4,7).
Infrapopliteal angioplasty is a critical procedure because of
the small diameter and length of the treated vessel, both of
which have a tendency toward a high re-stenosis rate;ritical limb ischemia.
Non-D.M ‘‘n= 20” % P-value
68.38 ± 2.5 – P < 0.03*
17 85.0%
3 15.0% P < 0.02*
10 50.0%









11 5.0% P < 0.001**
4 20.0%
Fig. 1 Arteriogram obtained in a 55-years-old diabetic patient
with non-healing ulcers and CLI. (a) Total occlusion of the
anterior tibial artery and non-visualized posterior tibial artery. (b)
Complete transluminal recanalization of the occluded anterior
tibial artery.
Table 2 Follow-up after infrapopliteal angioplasty in diabetic and non-diabetic groups.
Item D.M ‘‘n= 40” % Non-D.M ‘‘n= 20” % P-value
1-Clinical signs after 3 ms:
 Rest pain improvement 8/8 100.0% 9/9 100.0% –
 Ulcer healing 33/37 89.18% 14/15 93.3% P < 0.03*
2- ‘‘1 day” post procedure
Doppler ultrasound:
 Patent 40 100.0% 20 100.0% n.s
 Re-stenosis – – – –
 Re-occlusion – – – –
3- ‘‘3 ms” post procedure
Doppler Ultrasound:
 Patent 36 90.0% 19 95.0%
 Re-stenosis 1 2.5% 1 5.0% n.s
 Re-occlusion 3 7.5% – –
* P< 0.05 significant.
Fig. 2 Arteriogram obtained in a 65-years old non-diabetic
patient with rest pain and CLI. (a) Narrowing and multiple
stenotic segments involving the distal part of the posterior tibial
artery. (b) Good flow straight to the foot is restored after
transluminal angioplasty.
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popliteal angioplasty is due solely to technical success (15,16).
The technical success rate in the present study was 100% in
diabetic and non-diabetic groups. In the study by Hyeon et al.
(17) there were also no significant differences between the 2
groups in the technical success rate (78% of diabetic vs. 84%
in non-diabetic (P = 0.133)).In the present study, the 3 months clinical success rate
revealed that the ulcer healing was better in non-diabetic group
(89.1% in diabetics vs. 93.3% in non-diabetics) with significant
difference (P< 0.03). Also, in the study by Hyeon et al. (17) it
was shown that the ulcer healing was better in non-diabetic
group but with no significant differences between the 2 groups.
As regards the patency rate after 3 months, the present
study showed that the patency of treated infrapopliteal vessels
was better in non-diabetic than in diabetic groups (95.0% vs.
90.0%) respectively with no significant difference. Bosiers
et al. (18) found that the 3-months patency rate was unfavor-
able in diabetic patients compared with non-diabetic patients;
otherwise, the other outcomes (clinical success rate, limb sal-
vage and overall survival) showed no significant differences
between the 2 groups.
In this study, the occlusive peripheral arterial disease (PVD)
in diabetic patients is characterized by long, multiple, calcified
Fig. 3 Arteriogram obtained in 74-years old diabetic patient
with ischemic ulcer and gangrenous area involving the big toe. (a)
Multiple stenotic and occluded segments involving the anterior
and peroneal arteries with multiple collaterals refilling. (b)
Subintimal recanalization of the anterior tibial and peroneal
arteries with good flow is restorted to the toes.
Fig. 4 Arteriogram obtained in a 66-years old diabetic patient
with rest pain and ischemic ulcer at the plantar. (a) Non-visualized
anterior tibial and posterior tibial arteries with narrowing and
multiple stenotic segments involving the plantar artery. (b) Good
flow straight to the foot is restored after transluminal angioplasty
of anterior and posterior tibial arteries.
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lesions. This may explain the tendency toward lower primary
patency in diabetic patients during 3 months follow-up. Dia-
betic patients with CLI had poor collateral distribution due
to the depression of arteriogenic and collateral growth in
response to ischemia particularly in below the knee arteries,
Faglia et al. (19).
In diabetic patients, it is advisable to achieve direct blood
flow to the foot by an anterior or posterior tibial artery revas-
cularization, because the peroneal artery anatomically ends
above the ankle and its collaterals to the foot are usually
poorly developed.
5. Conclusion
Infrapopliteal angioplasty has acceptable clinical outcome and
is feasible as the primary choice of treatment in diabetic
patients with CLI. Diabetes mellitus is a risk factor signifi-
cantly affecting the 3-months clinical success rate, but is not
significantly affecting the technical success and the 3-months
patency rate.
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